0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letters |

Parathyroidectomy and Improving Anemia FREE

Tamara K. Jemcov, MD; Marijana Petakov, MD, PhD; Andrija Bogdanovic, MD; Ljubica Djukanovic, MD, PhD; Visnja D. Lezaic, MD, PhD
Arch Surg. 2008;143(1):97-98. doi:10.1001/archsurg.2007.26.
Text Size: A A A
Published online

We have read with great interest the article written by Chow and coworkers1 showing that anemia improved after total parathyroidectomy (PTX), especially in the patients who received therapy with human recombinant erythropoietin. As the mechanisms for the improvement were not considered in the article, we would like to share our results concerning increased erythropoiesis after PTX, even though they were obtained from an investigation of a small patient group.

Nine patients (5 men; mean [SD] age, 45.0 [15.4] years) who had been receiving regular hemodialysis for 76.8 [43.8] months were included in the study after subtotal PTX. All of them gave informed consent to participate in the study. Indication for PTX was based on clinical, biochemical, and radiological criteria.2 Three patients (patients 6, 7, and 8 in the Table) were positive for hepatitis virus B or C. None of the patients had iron deficiency anemia or blood loss, and none of them were treated with human recombinant erythropoietin before or after PTX. Histological examination found hyperplasia in all extirpated glands. The following laboratory analyses were done before and 6 months after PTX in all patients: hemoglobin, serum calcium, phosphorus, alkaline phosphatase, intact parathormone (iPTH) (radioimmunoassay; Nichols Institute Diagnostics, San Juan Capistrano, California) (normal values, 10-55 pg/mL), erythropoietin (Epo) (enzyme-linked immunosorbent assay 500; Medac, Wedel, Germany) (normal values for healthy nonanemic adults, 4-25 mU/mL), bone marrow burst-forming units erythroid (BFU-E) (assayed by methyl cellulose culture technique in vitro3), and bone marrow cellularity.

Table Graphic Jump LocationTable. Individual Values of Hemoglobin, Erythropoietin, Bone Marrow Burst-Forming Units Erythroid, and Intact Parathormone Before and After Parathyroidectomy

Six months after PTX, serum iPTH levels were 10 to 69 times lower than the initial value in all but 1 patient (Table). In the first 8 patients presented in the Table, mean (SD) iPTH levels decreased significantly (1453.7 [634.2] vs 71.0 [75.8] pg/mL, P = .02) after successful PTX. This was accompanied by increases of mean (SD) hemoglobin level (88.5 [19.4] vs 99.2 [10.7] g/L, P = .31) and mean (SD) serum Epo level (23.54 [21.1] vs 31.1 [22.5] IU/mL, P = .04) and a decline in mean (SD) BFU-E number (40.1 [12.5] vs 26.2 [10.6], P = .14). Individual data showed that serum Epo concentration increased after successful PTX in 6 of 8 patients. In 2 patients who were positive for hepatitis virus, serum Epo levels were higher than the normal range even before PTX. The increase of serum Epo levels was accompanied by greater hemoglobin values and increased bone marrow cellularity from proliferation of erythroblasts, which lowered the myeloid to erythroid ratio in the bone marrow (4.4:1 before and 1.8:1 after PTX). Numbers of BFU-E were decreased in all the patients with successful PTX (including the patient with high initial Epo).

The results presented show erythropoiesis stimulation after successful PTX by an increase in serum Epo, which suggests a direct inhibitory effect of PTH on Epo synthesis. These data are in concert with those obtained by others4 and confirm that even in patients with end-stage renal disease and without excretory kidney function, increase of erythropoietin synthesis could occur. Increased serum Epo before PTX found in 2 of our patients who were positive for hepatitis is in agreement with our previous results.5 However, in all patients with successful PTX, including these 2, bone marrow cellularity improved and BFU-E numbers decreased. That indicated that more efficacious erythroid maturation after successful PTX resulted not only from the increase of Epo synthesis but also from a decrease of bone marrow suppression. The role of PTH as a uremic toxin and inhibitor of erythropoiesis was described 2 decades ago.6

Successful PTX in 8 of 9 patients was followed with a manifold decrease of serum iPTH levels, increase of serum Epo level, more efficient maturation of the erythroid line, and alleviation of anemia.

ARTICLE INFORMATION

Correspondence: Dr Jemcov, Clinic of Nephrology, Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia (tamara@jemcov.com).

Author Contributions:Study concept and design: Jemcov and Lezaic. Analysis and interpretation of data: Jemcov, Petakov, Bogdanovic, Djukanovic, and Lezaic. Drafting of the manuscript: Petakov and Bogdanovic. Critical revision of the manuscript for important intellectual content: Djukanovic and Lezaic. Statistical analysis: Jemcov and Lezaic. Study supervision: Petakov, Djukanovic, and Lezaic.

Financial Disclosure: None reported.

Chow  TLChan  TTHo  YWLam  SH Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis. Arch Surg 2007;142 (7) 644- 648
PubMed
National Kidney Foundation, K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42 (4) ((suppl 3)) S1- S201
PubMed
Iscove  NNSieber  FWinterhalter  KH Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J Cell Physiol 1974;83 (2) 309- 320
PubMed
Yasunaga  CMatsuo  KYanagida  TMatsuo  SNakamoto  MGoya  T Early effects of parathyroidectomy on erythropoietin production in secondary hyperparathyroidism. Am J Surg 2002;183 (2) 199- 204
PubMed
Radovic  MJelkmann  WDjukanovic  LOstric  V Serum erythropoietin and interleukin-6 levels in hemodialysis patients with hepatitis virus infection. J Interferon Cytokine Res 1999;19 (4) 369- 373
PubMed
Meytes  DBofin  EMa  ADukes  PPMassry  SG The effect of parathyroid hormone on erythropoiesis. J Clin Invest 1981;67 (5) 1263- 1269
PubMed

Figures

Tables

Table Graphic Jump LocationTable. Individual Values of Hemoglobin, Erythropoietin, Bone Marrow Burst-Forming Units Erythroid, and Intact Parathormone Before and After Parathyroidectomy

References

Chow  TLChan  TTHo  YWLam  SH Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis. Arch Surg 2007;142 (7) 644- 648
PubMed
National Kidney Foundation, K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42 (4) ((suppl 3)) S1- S201
PubMed
Iscove  NNSieber  FWinterhalter  KH Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J Cell Physiol 1974;83 (2) 309- 320
PubMed
Yasunaga  CMatsuo  KYanagida  TMatsuo  SNakamoto  MGoya  T Early effects of parathyroidectomy on erythropoietin production in secondary hyperparathyroidism. Am J Surg 2002;183 (2) 199- 204
PubMed
Radovic  MJelkmann  WDjukanovic  LOstric  V Serum erythropoietin and interleukin-6 levels in hemodialysis patients with hepatitis virus infection. J Interferon Cytokine Res 1999;19 (4) 369- 373
PubMed
Meytes  DBofin  EMa  ADukes  PPMassry  SG The effect of parathyroid hormone on erythropoiesis. J Clin Invest 1981;67 (5) 1263- 1269
PubMed

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles